These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9836381)

  • 1. Anti-CD4 monoclonal antibodies in rheumatoid arthritis.
    Choy EH; Kingsley GH; Panayi GS
    Springer Semin Immunopathol; 1998; 20(1-2):261-73. PubMed ID: 9836381
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacokinetics and human anti-mouse antibody response in rheumatoid arthritis patients treated with a chimeric anti-CD4 monoclonal antibody.
    Choy EH; Schantz A; Pitzalis C; Kingsley GH; Panayi GS
    Br J Rheumatol; 1998 Jul; 37(7):801-2. PubMed ID: 9714366
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibodies to CD4.
    Breedveld FC
    Rheum Dis Clin North Am; 1998 Aug; 24(3):567-78. PubMed ID: 9710887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis.
    van der Lubbe PA; Reiter C; Breedveld FC; Krüger K; Schattenkirchner M; Sanders ME; Riethmüller G
    Arthritis Rheum; 1993 Oct; 36(10):1375-9. PubMed ID: 8216397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD4 therapy in rheumatoid arthritis.
    Choy EH; Kingsley GH
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S147-9. PubMed ID: 8100751
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination therapy in mice: what can we learn that may be useful for understanding rheumatoid arthritis?
    Williams RO
    Springer Semin Immunopathol; 1998; 20(1-2):165-80. PubMed ID: 9836375
    [No Abstract]   [Full Text] [Related]  

  • 7. Expectation bias in rheumatoid arthritis clinical trials. The anti-CD4 monoclonal antibody experience.
    Epstein WV
    Arthritis Rheum; 1996 Nov; 39(11):1773-80. PubMed ID: 8912498
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-CD4 monoclonal antibody therapy in human autoimmune diseases.
    Schulze-Koops H; Lipsky PE
    Curr Dir Autoimmun; 2000; 2():24-49. PubMed ID: 11791458
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody.
    Yoshizaki K; Nishimoto N; Mihara M; Kishimoto T
    Springer Semin Immunopathol; 1998; 20(1-2):247-59. PubMed ID: 9836380
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody.
    Horneff G; Burmester GR; Emmrich F; Kalden JR
    Arthritis Rheum; 1991 Feb; 34(2):129-40. PubMed ID: 1994909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody.
    Choy EH; Chikanza IC; Kingsley GH; Corrigall V; Panayi GS
    Scand J Immunol; 1992 Aug; 36(2):291-8. PubMed ID: 1354392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-CD4 therapy in treatment of rheumatoid arthritis--have the die been cast?].
    Keysser G; Alpermann U; Burmester GR
    Z Rheumatol; 1998 Oct; 57(5):320-5. PubMed ID: 9864838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate.
    Moreland LW; Pratt PW; Mayes MD; Postlethwaite A; Weisman MH; Schnitzer T; Lightfoot R; Calabrese L; Zelinger DJ; Woody JN
    Arthritis Rheum; 1995 Nov; 38(11):1581-8. PubMed ID: 7488278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of circulating tumor necrosis factor-alpha, interferon-gamma, and interleukin-2 in systemic reactions induced by anti-CD4 therapy in patients with rheumatoid arthritis.
    Horneff G; Krause A; Emmrich F; Kalden JR; Burmester GR
    Cytokine; 1991 May; 3(3):266-7. PubMed ID: 1909192
    [No Abstract]   [Full Text] [Related]  

  • 15. [New approaches to treatment in immunology with monoclonal antibodies].
    Rubbert A; Diehl V
    Internist (Berl); 2001 Jun; 42(6):843, 846-53. PubMed ID: 11449631
    [No Abstract]   [Full Text] [Related]  

  • 16. Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritis.
    Horneff G; Winkler T; Kalden JR; Emmrich F; Burmester GR
    Clin Immunol Immunopathol; 1991 Apr; 59(1):89-103. PubMed ID: 2019013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of rheumatoid arthritis with a chimeric CD4 monoclonal antibody (cM-T412): immunopharmacological aspects and mechanisms of action.
    van der Lubbe PA; Reiter C; Miltenburg AM; Krüger K; de Ruyter AN; Rieber EP; Bijl JA; Riethmüller G; Breedveld FC
    Scand J Immunol; 1994 Mar; 39(3):286-94. PubMed ID: 8128188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anti-CD4 antibody treatment on inflammatory arthritis in MRL-lpr/lpr mice.
    Gilkeson GS; Spurney R; Coffman TM; Kurlander R; Ruiz P; Pisetsky DS
    Clin Immunol Immunopathol; 1992 Aug; 64(2):166-72. PubMed ID: 1353712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD4 antibody treatment of patients with rheumatoid arthritis: II. Effect of in vivo treatment on in vitro proliferative response of CD4 cells.
    Walker C; Herzog C; Rieber P; Riethmüller G; Müller W; Pichler WJ
    J Autoimmun; 1989 Oct; 2(5):643-9. PubMed ID: 2572231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells.
    Herzog C; Walker C; Müller W; Rieber P; Reiter C; Riethmüller G; Wassmer P; Stockinger H; Madic O; Pichler WJ
    J Autoimmun; 1989 Oct; 2(5):627-42. PubMed ID: 2572230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.